SCAP.BK▲
WINMED, IROYAL, SCAP report strong second-half earnings
Three Thai listed companies reported strong second-half results. WINMED posted second-quarter 2026 profit of 6.40 million baht, up 237%, with total revenue of 209.22 million baht, driven by growth in blood recruitment products and services and cell and molecular technology products. Management said the second-half outlook is bright after its Pathogen Inactivation innovation was well received by public and private hospitals, and it is moving ahead with launching Thailand's first mobile platelet donation bus. IROYAL reported first-half 2026 total revenue of 232.73 million baht and net profit of 65.91 million baht, up 34%, with a backlog of 620 million baht and projects ready for bidding in 2026 to 2027 worth more than 2.5 billion baht. The board approved an interim dividend of 0.1304 baht per share. SCAP posted record profit in the second quarter of 2026, with total revenue of 1.45555 billion baht and net profit of 477.35 million baht, up 155.05% from the same period last year, driven by motorcycle hire-purchase lending and mobile phone hire-purchase lending through the Locked Phone system, along with effective control of debt quality and expenses.